Work

Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden

Year: 2008

Type: article

Source: Multiple Sclerosis Journal

DOI: 10.1177/1352458507086667

Authors: G Kobelt, J Berg, P Lindgren, B Jonsson, L Stawiarz, J Hillert

Institutions: Lund University, Karolinska Institutet, Uppsala University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2139255064

FWCI: 6.639

Cites: 30

Cited by: 51

Related to: 10